about
Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literatureProcalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunctionSuccessful photo-and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II.Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patientsSerum procalcitonin as a diagnostic marker of neonatal sepsis.Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in miceSignificance of serum procalcitonin in sepsisDiagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.Characteristics of serum endocan levels in infection.Clinical impact of kidney function on presepsin levels.Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranesPathophysiology and diagnostic value of urinary trypsin inhibitors.The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.Cardiorenal biomarkers in acute heart failure.The role of procalcitonin in neonatal intensive care unit patients with candidemia.Procalcitonin kinetics - prognostic and diagnostic significance in septic patientsEarly serum procalcitonin level after primary total hip replacementPro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients.Biomarkers for sepsis: a review with special attention to India.Biomarkers in the diagnosis of aspiration syndromes.Postmortem chemistry update part II.Utility of procalcitonin as a biomarker for rejection and differentiation of infectious complications in lung transplant recipients.Procalcitonin and intestinal ischemia: a review of the literature.Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review.Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge.Influence of the postoperative inflammatory response on cognitive decline in elderly patients undergoing on-pump cardiac surgery: a controlled, prospective observational study.Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis: A cross-sectional study.Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.Rapid and Sensitive Lateral Flow Immunoassay Method for Procalcitonin (PCT) Based on Time-Resolved Immunochromatography.Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.The Association Between Serum Procalcitonin Levels and Severity of Coronary Artery Disease Assessed by SYNTAX Score in Patients With Acute Coronary Syndrome.Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.Diagnostic Value of Procalcitonin Levels in Acute Mesenteric Ischemia.The use of procalcitonin as a marker of sepsis in children.Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient.Procalcitonin-guided antibiotics in severe sepsis.Nonconventional Markers of Sepsis.Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood.
P2860
Q21195047-A1740E8D-313F-47C0-A05D-EABA3B66620DQ24800762-2437D9E2-C92E-49F1-BE0F-19475E66A3DFQ33221134-853AC688-BC3E-44CE-8FD7-2E5759133DC3Q33385335-8811D589-4A55-4278-88B4-18C7B84B352FQ34451327-68BB9F3E-C09E-4F1B-B6D7-B9AAFB99734CQ34632004-175F3DEC-9EAD-4A3A-83B0-2A0EE543DFA6Q34991149-419FCB84-C23F-452A-AEEE-309A96348179Q35007561-AFF277D7-2DA1-480D-82B9-BE7428EA3F91Q35500737-27708555-3B95-4F2E-BD27-201395C70092Q35648243-880EBB43-B83E-4528-A9B6-DFCD467DB7B9Q35925367-CDB962F4-4614-43BB-8991-B714824DF4B3Q36011173-85601464-ADF8-418D-90F4-CD1ECC84AE16Q36131387-526FD04B-3E50-4406-9E68-EBB76D14CEFAQ36313675-FAF4C0C2-AFEE-4210-9EB9-99C899436B4AQ36465021-6584BF43-3566-4FAF-9673-5CFE69378395Q36582374-B407B1DA-F963-49ED-921F-052AB9815AAFQ36882700-CA728997-EA4B-474C-BA8E-DFC5E0F4B10AQ37157970-4476354D-E165-45B6-8CCF-80270CA445CCQ37333679-9BD3EEA8-8826-4C36-B239-A6963B3549E3Q37688126-C51B55A1-C821-47B2-9287-6EB370DCE91CQ37724872-471FCFB7-1C70-4A03-94FB-2DA0FB40C8E0Q37943748-D62328B4-98BB-460E-A202-8D6B251F7B15Q38164662-3C7B49A8-5C38-4965-A8B7-1A3C263D95F6Q38303532-76AC600E-112A-42C3-B816-66FDE8AD0A13Q38414470-2994B067-2BFF-413B-AED7-7B1D215DC5B5Q38463009-320107E9-22BA-4914-B372-98F90D7ECC0BQ38603446-F08A3B6D-A3DA-4DB4-92AD-3F7C25B7B3C4Q40063295-2DA54FB0-15B8-424B-8927-0C1F48E27B4EQ40237535-56D357EA-7178-4D55-9E0C-54DB579B9229Q40306437-16D9FC9B-E44E-4631-8004-B34C52DB0EB8Q40337728-73306AF9-165F-4667-B344-8FB418AAFEA0Q40533389-79150AE4-7B3B-4519-8982-58E8F5C1A1C2Q40745918-B4815C18-EE9E-49BE-999B-866E06AA3B02Q40816694-96021A19-2F27-4517-9A6C-EAD7C2CE207CQ41167105-5496E4FA-3F65-4D3E-BB83-1483131E9B30Q41436622-BA1B1CFF-138B-4A55-A385-56768D6B1650Q41692073-03DD4FD9-758B-47ED-9E87-49982801A3C5Q42021025-93986953-29D1-44BF-A5C4-07F9BCB216BCQ42220252-6A498D79-4023-4B74-BD68-D1820AFC6786Q43640031-1696C1C8-5508-41C4-8B05-983EC0A3761A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathobiochemistry and clinical use of procalcitonin.
@ast
Pathobiochemistry and clinical use of procalcitonin.
@en
Pathobiochemistry and clinical use of procalcitonin.
@nl
type
label
Pathobiochemistry and clinical use of procalcitonin.
@ast
Pathobiochemistry and clinical use of procalcitonin.
@en
Pathobiochemistry and clinical use of procalcitonin.
@nl
prefLabel
Pathobiochemistry and clinical use of procalcitonin.
@ast
Pathobiochemistry and clinical use of procalcitonin.
@en
Pathobiochemistry and clinical use of procalcitonin.
@nl
P1433
P1476
Pathobiochemistry and clinical use of procalcitonin.
@en
P2093
Michael Meisner
P356
10.1016/S0009-8981(02)00101-8
P577
2002-09-01T00:00:00Z